RE:The FDA cannot turn down such treatment Exactly! What the data clearly shows is a high CR efficacy and a very high durable efficacy with only 2 treatments, and high safety. Hence, no other drug to date has seen this level of activity, as all other treatments need to be continued with many maintenance treatments in order to maintain CR status, When do we get AA? All IMO